Aki Pui‐Wah Tse
Hong Kong Science and Technology Parks Corporation(HK)University of Hong Kong(HK)
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Eicosanoids and Hypertension Pharmacology, RNA modifications and cancer, Epigenetics and DNA Methylation, Cancer, Lipids, and Metabolism
Most-Cited Works
- → Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2/CD39L1 in hepatocellular carcinoma(2017)447 cited
- → Hypoxia induces myeloid‐derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C‐C motif) ligand 26(2016)231 cited
- → Hypoxia regulates the mitochondrial activity of hepatocellular carcinoma cells through HIF/HEY1/PINK1 pathway(2019)193 cited
- → Induction of Oxidative Stress Through Inhibition of Thioredoxin Reductase 1 Is an Effective Therapeutic Approach for Hepatocellular Carcinoma(2018)174 cited
- → Folate cycle enzyme MTHFD1L confers metabolic advantages in hepatocellular carcinoma(2017)158 cited
- → Ferroptosis Suppressor Protein 1 Inhibition Promotes Tumor Ferroptosis and Anti-tumor Immune Responses in Liver Cancer(2023)103 cited
- → Hypoxia-induced macropinocytosis represents a metabolic route for liver cancer(2022)102 cited
- → Switching of Pyruvate Kinase Isoform L to M2 Promotes Metabolic Reprogramming in Hepatocarcinogenesis(2014)91 cited
- → NDUFA4L2 Fine-tunes Oxidative Stress in Hepatocellular Carcinoma(2016)87 cited
- → Using mouse liver cancer models based on somatic genome editing to predict immune checkpoint inhibitor responses(2022)56 cited